2nd Quarter - Report
FOLEY HOAG LLP for ABBOTT LABORATORIES
Firm
Client
Income
$30,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
FDA legislation and regulatory implementation issues. Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011
| Lobbyist | Covered position, as disclosed |
|---|---|
| J KEVIN BRENNAN | — |
| PAUL KIM | — |
Food Industry (safety, labeling, etc.) FOO
S.510 FDA Food Safety Modernization Act; H.R. 2749 Food Safety Enhancement Act of 2009; S. 3307 Healthy, Hunger-Free Kids Act of 2010; H.R. 5504 Improving Nutrition for America's Children Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| J KEVIN BRENNAN | — |
| PAUL KIM | — |
Copyright/Patent/Trademark CPT
H.R. 1249 America Invents Act of 2011; S. 23 Patent Reform Act of 2011
| Lobbyist | Covered position, as disclosed |
|---|---|
| J KEVIN BRENNAN | — |
| PAUL KIM | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.